BHLHE22, targeted by deubiquitinating enzyme OTUD3, exerts an antitumor role in triple-negative breast cancer progression via transcriptionally inhibiting CDT1

Authors

Institutions

Publication Details

Journal
Breast Cancer Research
Published
2026-01-02
DOI
https://doi.org/10.1186/s13058-025-02198-0
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

BHLHE22, targeted by deubiquitinating enzyme OTUD3, exerts an antitumor role in triple-negative breast cancer progression via transcriptionally inhibiting CDT1

Y. Zhang, Lei Jiang, Junnan Xu, Cui Jiang et al.
Breast Cancer Research
Ubiquitin and proteasome pathways
article

BHLHE22, targeted by deubiquitinating enzyme OTUD3, exerts an antitumor role in triple-negative breast cancer progression via transcriptionally inhibiting CDT1

Y. Zhang, Lei Jiang, Junnan Xu, Cui Jiang, Yufeng Jia, Tao Sun
article en

Abstract

No abstract available for this paper.
Breast Cancer ResearchVol. 28(1)
First Hospital of China Medical University (CN), Liaoning Cancer Hospital & Institute (CN), China Medical University (CN)
Good health and well-being
Openalex Percentile: Top 98%
Ubiquitin and proteasome pathways
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

BHLHE22, targeted by deubiquitinating enzyme OTUD3, exerts an antitumor role in triple-negative breast cancer progression via transcriptionally inhibiting CDT1 — Y. Zhang, Lei Jiang, et al. · Breast Cancer Research (2026) | TGRS Research Map | TGRS